Pulmonary Mycobacterium malmoense and aspergillus infection: a fatal combination?

FG Böllert, PJ Sime, W MacNee, GK Crompton - Thorax, 1994 - ncbi.nlm.nih.gov
Three patients with chronic obstructive pulmonary disease developed coexisting
Mycobacterium malmoense and aspergillus infection. All suffered progressive lung …

Recombinant DNase in cystic fibrosis: a protocol for targeted introduction through n-of-1 trials. Scottish Cystic Fibrosis Group

FG Bollert, JY Paton, TG Marshall… - European …, 1999 - Eur Respiratory Soc
Nebulized recombinant human deoxyribonuclease (DNase) reduces sputum viscosity and
improves lung function in some cystic fibrosis patients, but individual responses are …

Non-tuberculous pulmonary infections in Scotland: a cluster in Lothian?

FG Böllert, B Watt, AP Greening, GK Crompton - Thorax, 1995 - thorax.bmj.com
BACKGROUND--A retrospective study was carried out to confirm the clinical impression that,
in Lothian, non-tuberculous mycobacterial infections are as common as pulmonary …

Comparative efficacy and potency of ipratropium via Turbuhaler and pressurized metered-dose inhaler in reversible airflow obstruction

FG Bollert, SP Matusiewicz, MH Dewar… - European …, 1997 - Eur Respiratory Soc
Ipratropium bromide (IB), typically delivered by pressurized metered dose inhaler (pMDI), is
used to treat patients with reversible airways obstruction. Use of the pMDI, unlike the …

[CITATION][C] Pulmonary Mycobacterium malmoense and aspergillosis and steroid therapy

B FG - Eur Respir J., 2005 - cir.nii.ac.jp
BOLLERT FG

[PDF][PDF] Non-tuberculous pulmonary infections in Scotland: a cluster in Lothian?

H Carruthers - BMJ, 1993 - researchgate.net
Background-A retrospective study was carried out to confirm the clinical impression that, in
Lothian, non-tuberculous mycobacterial infections are as common as pulmonary tuberculosis. …

[CITATION][C] Placebo‐controlled n‐of‐1 trials in cystic fibrosis

FG Böllert, J Innes - European Respiratory Journal, 1999 - Wiley Online Library
Placebo‐controlled n‐of‐1 trials in cystic fibrosis - Böllert - 1999 - European Respiratory
Journal - Wiley Online Library …

Clinical trials of orphan medicines

BM Buckley - The Lancet, 2008 - thelancet.com
SG’s department has provided support to organisations for several projects discussed in the
text. These awards were part of the usual grant and contract mechanisms of the US National …

Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis

H Kunst, M Wickremasinghe, A Wells… - European Respiratory …, 2006 - Eur Respiratory Soc
The aim of the present study was to determine whether patients with bronchiectasis and
nontuberculous mycobacteria (NTM) have a higher prevalence of Aspergillus-related lung …

Effect of DNase on exercise capacity in cystic fibrosis

M Barker, E Franke, M Böhle… - Pediatric …, 2004 - Wiley Online Library
DNase can reduce viscosity and facilitate expectoration of airway secretions in cystic fibrosis
(CF) lung disease. We evaluated its effect on exercise performance in relation to resting …